Pernicious anemia in chinese: A study of 181 patients in a Hong Kong hospital

Medicine

Volumn 85, Issue 3, 2006, Pages 129-138

  Chan, Joyce Chee Wun ^a   Liu, Herman Sung Yu ^a   Kho, Bonnie Chi Sang ^a   Sim, Joycelyn Pui Yin ^a   Lau, Thomas Kwan Hang ^a   Luk, Yiu Wing ^a   Chu, Raymond Wan ^a   Cheung, Florence Man Fung ^a   Choi, Frankie Pak Tat ^a   Ma, Edmond Shiu Kwan ^a,b  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; INTRINSIC FACTOR;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ATROPHY; BLOOD GROUP ABO SYSTEM; BLOOD LEVEL; CELL HYPERPLASIA; CHINESE; CHRONIC GASTRITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; HONG KONG; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEGALOBLASTIC ANEMIA; NEUROLOGIC DISEASE; PERNICIOUS ANEMIA; PRIORITY JOURNAL; SCHILLING TEST; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH PARIETAL CELL; STOMACH POLYP;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, PERNICIOUS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLUOROIMMUNOASSAY; HONG KONG; HOSPITALIZATION; HUMANS; INTRINSIC FACTOR; MALE; MIDDLE AGED; PARIETAL CELLS, GASTRIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SCHILLING TEST; SEROLOGIC TESTS; VITAMIN B 12;

EID: 33744789968     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000224710.47263.70     Document Type: Article

References (67)

1. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency. I: Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:90-98.
2. Appelmelk BJ, Faller G, Claeys D, Kirchner T, Vandenbroucke-Grauls CMJE. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today. 1998;19:296-299.
3. Au WY, Hui CH, Chan LC, Liang RHS, Kwong YL. Clinicopathological features of megaloblastic anaemia in Hong Kong: a study of 84 Chinese patients. Clin Lab Haem. 1998;20:217-219.
4. Carmel R, Spencer CA. Clinical and subclinical thyroid disorders associated with pernicious anemia. Arch Intern Med. 1982;142:1465-1469.
5. Carmel R. Clinical aspects of megaloblastic anemia. In: Bick RL, ed. Hematology: Clinical and Laboratory Practice. St. Louis: Mosby; 1993:437-457.
6. Carmel R. Ethnic and racial factors in cobalamin metabolism and its disorders. Semin Hematol. 1999;36:88-100.
7. Carmel R, Green R, Jacobsen DW, Qian GD. Neutrophil nuclear segmentation in mild cobalamin deficiency - relation to metabolic tests of cobalamin status and observations on ethnic differences in neutrophil segmentation. Am J Clin Pathol. 1996;106:57-63.
8. Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol. 1988;90:442-445.
9. Carmel R. Pernicious anemia - the expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking. Arch Intern Med. 1988;148:1712-1714.
10. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097-1100.
11. Carmel R, Ozturk G, Johnson CS, Tung KSK, Terasaki PI. Profiles of black and Latin-American patients having pernicious anemia: HLA antigens, lymphocytotoxic antibody, anti-parietal cell antibody, serum gastrin levels and ABO blood groups. Am J Clin Pathol. 1981;75:291-296.
12. Carmel R, Johnson CS. Racial patterns in pernicious anemia: early age of onset and increased frequency of intrinsic factor antibody in black women. N Engl J Med. 1978;298:647-650.
13. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol. 1992;89:74-77.
14. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. In: Education Program Book, American Society of Hematology. San Diego, California; 2003:62-81.
15. Chan JCW, Liu HSY, Kho BCS, Chu RW, Ma ESK, Ma KM, Choi PT. Megaloblastic anaemia in Chinese patients: a review of 52 cases. Hong Kong Med J. 1998;14:269-274.
16. Chan JCW, Liu HSY, Kho BCS, Sim JPY. Pernicious anaemia in Chinese [abstract]. In: The 10th Congress of the International Society of Hematology, Asian-Pacific Division. Nagoya, Japan. 2004:169.
17. Chan JCW, Liu HSY, Leung JCK, Chu RW, Ma ESK, Ma KM, Choi PT. Pernicious anaemia in Chinese patients: a review of 39 cases in Hong Kong. Br J Haematol. 1998;102:45.
18. Chanarin I, Metz J. Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol. 1997;97:695-700.
19. Chanarin I. Pernicious anaemia. In: The Megaloblastic Anaemias. 1st ed. Oxford: Blackwell Scientific Publications; 1969:457-466.
20. Chanarin I. Pernicious anaemia. In: The Megaloblastic Anaemias. 2nd ed. Oxford: Blackwell Scientific Publications; 1979.
21. Chanarin I, Stephenson E. Vegetarian diet and cobalamin deficiency: their association with tuberculosis. J Clin Pathol. 1988;41:759-762.
22. Chang YM, Tsou YF, Hsu HK, Wei TH. Pernicious anaemia of Addisonian type: report of a case in a Chinese. Chin Med J. 1957;75:485.
23. Fong TL, Dooley CP, Dehesa M. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology. 1991;100:328-332.
24. Fu WT, Sturton SD. A severe case of pernicious anaemia. Chin Med J. 1926;40:1016.
25. Green R. Cobalamin and folate deficiency: the antecedents and associations of anemia. In: Education Program of the 26th Congress of the International Society of Haematology. Singapore: International Society of Haematology, Asian-Pacific Division; 1996:128-136.
26. Green R, Kuhl W, Jacobson R, Johnson C, Carmel R, Beutler E. Masking of macrocytosis by α-thalassemia in blacks with pernicious anemia. N Engl J Med. 1982;307:1322-1325.
27. 12 deficiency: caveat emptor. Ann Intern Med. 1996;124:509-511.
28. Haruma K, Komoto K, Kawaguchi H, Okamoto S. Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. Am J Gastroenterol. 1995;90:1107-1110.
29. Herbert V. Pernicious anemia and other megaloblastic anemias. Available at: http://www.victorherbert.com/Conn'sCurrentTherapy2003.htm. Accessed 12/12/05.
30. Hoffbrand AV. Megaloblastic anaemia and miscellaneous deficiency anaemias. In: Warrell DA, ed. Oxford Textbook of Medicine. 4th ed. Oxford: Oxford University Press; 2003:659-675.
31. Hoskins LC, Loux HA, Britten A, Zamcheck N. Distribution of ABO blood groups in patients with pernicious anemia, gastric carcinoma and gastric carcinoma associated with pernicious anemia. N Engl J Med. 1965;273:633-637.
32. Hsing AW, Hansson L-E, McLaughlin JK, Nyren Olle, Blot WJ, Ekbom Anders, Fraumeni JF. Pernicious anemia and subsequent cancer: a population-based cohort study. Cancer. 1993;71:745-750.
33. Hvas AM, Vestergaard H, Gerdes LU, Nexo E. Physicians' use of plasma methylmalonic acid as a diagnostic tool. J Intern Med. 2000;247:311-317.
34. Irvine WJ, McFadzean AJS, Todd D, Tso SC, Yeung RTT. Pernicious anaemia in the Chinese: a clinical and immunological study. Clin Exp Immunol. 1969;4:375-386.
35. Jayaratnam FJ, Cheng SS, Da Costa JL, Tan KK, O'Brien W. Pernicious anaemia among Asians in Singapore. Br Med J. 1967;3:18-20.
36. Joosten E. Strategies for the laboratory diagnosis of some common causes of anaemia in elderly patients. Gerontology. 2004;50:49-56.
37. 12 deficiency? Arch Intern Med. 2000;160:1349-1353.
38. 12 and folate. Clin Chem. 2000;46:8(B)1277-1283.
39. Krassas G, McHardy-Young S, Ramsay I, Florin-Christensen A. Thyroid function and antibody studies in pernicious anaemia. Clin Endocrinol. 1977;6:145-151.
40. Leong S, Mak KH, Chua E. Blood groups distribution among Chinese donors in Hong Kong [abstract]. In: 19th Congress of the International Society of Blood Transfusion. Sydney; 1986.
41. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency. II: Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990;34:99-107.
42. Lindenbaum J, Nath BJ. Megaloblastic anaemia and neutrophil hypersegmentation. Br J Haematol. 1980;44:511-513.
43. Lindenbaum J, Healton EB, Savage DG, Brust JCM, Garrett TJ, Podell ER, Marcell PD, Stabler SP, Allen RH. Neuropsychiatrie disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318:1720-1728.
44. Metz J, McNeil AR, Levin M. The relationship between serum cobalamin concentration and mean red cell volume at varying concentrations of serum folate. Clin Lab Haem. 2004;26:323-325.
45. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr. 2002;132:2799-2803.
46. Ng SC, Kuperan P, Chan KS, Bosco J, Chan GL. Megaloblastic anaemia - a review from University Hospital, Kuala Lumpur. Ann Acad Med Singapore. 1988;17:261-266.
47. Nilsson K, Gustafson L, Faldt R, Anderson A, Vaara I, Nilsson R, Alm B. Plasma methylmalonic acid in relation to serum cobalamin and plasma homocysteine in a psychogeriatric population and the effect of cobalamin treatment. Int J Geriatr Psychiat. 1997;12:67-72.
48. Ottesen M, Feldt-Rasmussen U, Andersen J, Hippe E, Schouboe A. Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment. J Endocrinol Invest. 1995;18:91-97.
49. Perez-Perez GI. Role of Helicobacter pylori infection in the development of pernicious anemia. Clin Infect Dis. 1997;25:1020-1022.
50. Savage DG, Ogundipe A, Allen RH, Stabler SP, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000:319:343-352.
51. Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Bailliere's Clin Haematol. 1995;8:657-678.
52. 12 deficiency is the primary cause of megaloblastic anaemia in Zimbabwe. Br J Haematol. 1994;86:844-850.
53. Schwartz SO, Rappolt LA. Pernicious anemia in Chinese. Arch Intern Med. 1945;75:404.
54. Shih LY. Pernicious anemia: a clinical study of 5 cases with special reference to morphological abnormalities, gastric secretion and autoantibodies. J Formos Med Assoc. 1980;79:593-607.
55. Sjoblom SM, Sipponen P, Jarvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut. 1993;34:28-32.
56. Solanki DL, Jacobson RJ, Green R, McKibbon J, Berdoff R. Pernicious anemia in blacks, a study of 64 patients from Washington, D.C., and Johannesburg. Am J Clin Pathol. 1981;75:96-99.
57. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood. 2005;105:978-985.
58. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76:871-881.
59. Stopeck A. Links between helicobacter pylori infection, cobalamin deficiency, and pernicious anemia. Arch Intern Med. 2000;160:1229-1230.
60. 12 deficiency. Acta Haematol. 1989;81:186-191.
61. Tuberculosis and Chest Service of the Department of Health, Annual Report. Hong Kong: Department of Health, Hong Kong Government. 2003.
62. 12 levels in relation to sex and age. Clin Lab Haem. 1997;19:27-31.
63. Williams TH. Pernicious anaemia in Szechwan: a case report. Chin Med J. 1932;46:673.
64. Xiao SD, Jiang SJ, Shi Y, Zhang DZ, Hu YB, Liu WZ, Yuan JM. Pernicious anemia and type A atrophic gastritis in the Chinese. Chin Med J. 1990;103:192-196.
65. Yang CS, Chang SL. The treatment of neurological manifestations of pernicious anaemia: report of a case. Chin Med J. 1938;53:469.
66. Yang CS, Keefer CS. Pernicious anaemia in Chinese patients: report of a case. Nat Med J China. 1931;17:218.
67. You JY, Chen CC, Lin EK, Ho CH. The characteristics of megaloblastic anemia associated with thalassemia. Haematologica. 2002;87:550-551.